在喘治疗中准interleukin途径
1Experimental Studies, Airway Disease Section, National Heart and Lung Institute, Imperial College London, London, UK; National Institute for Health Research (NIHR), Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Trust and Imperial College London, London, UK.
Lancet (London, England)
|September 19, 2015
概括
阻断T-助手-2 (Th2) 细胞因子的向治疗对严重的酸性喘具有前景. 生物标志物对于识别将受益于这些先进治疗的患者至关重要.
科学领域:
- 免疫学
- 肺病学
- 药理学
背景情况:
- 喘是一种复杂的呼吸系统疾病,尽管接受了标准治疗,但仍有一部分患者出现严重症状.
- 严重喘的特点是控制不良,频繁恶化,持续阻塞空气流.
- 在近一半的严重喘病例中,来自T-助手-2 (Th2) 细胞的白血素 (IL-4,IL-5,IL-13) 参与了酸性和过敏性炎症.
研究的目的:
- 审查Th2驱动炎症在严重喘中的作用.
- 评估针对性生物治疗的疗效,包括抗IgE和抗细胞因子单克隆抗体,用于严重的喘.
- 讨论生物标志物的潜力,以指导严重喘的治疗决策.
主要方法:
- 对严重喘病理生理学和治疗的现有文献的审查.
- 对针对性治疗研究的分析,如奥马利祖马布,抗IL-5,抗IL-4Rα和抗IL-13抗体.
- 检查临床结果,包括恶化,喘控制和肺功能 (FEV1).
主要成果:
- 抗IgE治疗 (奥马利祖马布) 对严重的过敏性喘有效.
- 针对IL- 5,IL- 4Rα或IL- 13的单克隆抗体已在严重酸性喘患者中显示出改善的结果.
- 美国食品和药物管理局 (FDA) 已推抗IL-5抗体用于严重的酸性喘,这表明抗Th2药物具有治疗作用.
结论:
- 针对性的抗Th2生物疗法在治疗严重酸性喘方面取得了重大进展.
- 鉴定生物标志物对于选择适合这些选择性抗体治疗的患者至关重要.
- 目前的治疗方法不能治疗由低Th2表达的非酸性炎症引起的喘.
相关概念视频
Antiasthma Drugs: Leukotriene Modifiers
2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.3K
Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
Asthma-II: Pathophysiology and Classification
4.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.9K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
2.0K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
2.0K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.3K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K


